JP Patent

JP5301152B2 — 神経成長因子アンタゴニストを投与することによって骨癌の疼痛を処置するための方法

Assigned to University of Minnesota Twin Cities · Expires 2013-09-25 · 13y expired

What this patent protects

Patent listed against Brinsupri.

Drugs covered by this patent

Patent Metadata

Patent number
JP5301152B2
Jurisdiction
JP
Classification
—
Expires
2013-09-25
Drug substance claim
No
Drug product claim
No
Assignee
University of Minnesota Twin Cities
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.